Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. (SHA:600613)

Market Cap	3.25B -1.7%
Revenue (ttm)	1.88B -14.1%
Net Income	62.34M +23.7%
EPS	0.11 +12.1%
Shares Out	534.07M
PE Ratio	57.87
Forward PE	n/a
Dividend	0.15 (2.39%)
Ex-Dividend Date	Jun 5, 2025

Volume	23,525,100
Average Volume	21,042,445
Open	6.38
Previous Close	6.28
Day's Range	6.25 - 6.48
52-Week Range	5.37 - 7.53
Beta	0.64
RSI	54.00
Earnings Date	Apr 30, 2026

About SHA:600613

Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd., together with its subsidiaries, operates as a pharmaceutical manufacturing holding investment company in China. The company engages in the research and development, and production of anti-tumor, cardiovascular, cerebrovascular, rheumatism bone pain, tonic and sedative, cold and cough, anti-fungal, gynecology, and other treatment fields. Its products include prescription drugs and OTC products, including products include sodium cantharidate vitamin B6 injection, sodium cantharidin i...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1990
• Employees: 1,266
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 600613

Financial Performance

In 2024, SHA:600613's revenue was 2.05 billion, a decrease of -12.48% compared to the previous year's 2.34 billion. Earnings were 71.39 million, an increase of 25.24%.